Public Act 103-0659
HB4055 EnrolledLRB103 31972 BMS 60758 b HB4055 Enrolled LRB103 31972 BMS 60758 b
HB4055 Enrolled LRB103 31972 BMS 60758 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Prior Authorization Reform Act is amended
by adding Section 77 as follows:
(215 ILCS 200/77 new)
Sec. 77. Prior authorization for drug therapies for
hereditary bleeding disorders. Notwithstanding any other
provision of law, a health insurance issuer or a contracted
utilization review organization may not require a prior
authorization for drug therapies approved by the U.S. Food and
Drug Administration for the treatment of hereditary bleeding
disorders any more frequently than 6 months or the length of
time the prescription for that dosage remains valid, whichever
period is shorter.
HB4055 Enrolled LRB103 31972 BMS 60758 b